Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Mechanism Behind Monitoring of Neuromuscular Blockers Discovered
Scientific Advances

Mechanism Behind Monitoring of Neuromuscular Blockers Discovered

By Roger AndersonJul 18, 2013
Share
Facebook Twitter Email
Eugene Silinsky, PhD, chair of molecular pharmacology and biological chemistry, recently published a paper in Anesthesiology that challenges a long-standing belief regarding neuromuscular blockers.

Neuromuscular blockers have been used for decades to paralyze muscles prior to surgery, but new Northwestern Medicine® research may change a basic assumption regarding the monitoring of their effectiveness.

Published in Anesthesiology, the study by Eugene Silinsky, PhD, chair of molecular pharmacology and biological chemistry, has found that a reduction in calcium channel activity, and not a depletion of neurotransmitters as previously thought, are responsible for the decreased response in treated muscles.

Silinsky’s work revolved around the Train of Four, a test used by anesthesiologists to evaluate the degree of disruption, or effectiveness, of neuromuscular blocking drugs. The decrease in muscle response seen during the test has for years been attributed to a depletion of a specific neurotransmitter, Silinsky said. But because the test affects a very small percentage of the total transmitter pool, he hypothesized that that an alternative mechanism – calcium channels – was at play.

“We know that the nerve impulse opens calcium channels and that the calcium sets off a chain of events to release neurotransmitters, resulting in the biological response of muscle twitches,” Silinsky said. “During our test, we zeroed in on the calcium channels and not neurotransmitters as the cause of the decrease in muscle response.”

Since the degeneration of muscles in many neuromuscular diseases mimics the effects of neuromuscular blocking drugs, the finding could prove helpful in developing new therapies.

Already used to treat airway disorders by stimulating voluntary muscle contraction for easier breathing, Silinsky and other scientists are currently looking into new applications of theophylline medications, or calcium channel blockers, based on his findings.

Scientist, Chair, Mentor

When Silinsky became chair of molecular pharmacology and biological chemistry nearly 18 years ago, he assumed the role as he was finishing a paper.

“I said to myself, ‘I should keep doing this; it might encourage other faculty who want to remain active in the process of scientific discovery.’ I realized afterwards that it was also good for my own mental stimulation,” he said.

While he has greatly enjoyed working with graduate students, post-doctoral fellows, visiting professors, and currently with Timothy Searl, PhD, research assistant professor in molecular pharmacology and biological chemistry, Silinsky has conducted and published his own work, culminating with this most recent paper, which took four to five years to complete.

“This piece published in Anesthesiology is ‘Chair Sanity Paper No. 5’,” he joked. “I think it’s important with the difficulties in obtaining National Institutes of Health (NIH) funding and with sequestration to encourage scientists to continue with their own experiments and not only have postdocs and graduate students doing the actual research. It is an important element for quality control and also hopefully generates a certain amount of camaraderie within the department. If faculty, postdocs, students and the department chair are all active in the process of scientific discovery, it is good for everyone involved.”

Silinsky’s work on Train-of-Four mechanisms was funded by an NIH supramodular grant active from 1976-2008 (R01 NS12782).

Pharmacology Research
Share. Facebook Twitter Email

Related Posts

Understanding How Hormones Influence Anemia

May 25, 2023

Groundbreaking Geneticist Delivers Epigenetics Lecture

May 24, 2023

CT Scan Best at Predicting Heart Disease Risk in Middle Age

May 23, 2023

Comments are closed.

Latest News

Celebrating Advances in Alzheimer’s Research and Clinical Care

May 26, 2023

Understanding How Hormones Influence Anemia

May 25, 2023

Groundbreaking Geneticist Delivers Epigenetics Lecture

May 24, 2023

CT Scan Best at Predicting Heart Disease Risk in Middle Age

May 23, 2023

Investigating the Benefits of Salt Substitutes in Elderly Patients

May 22, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230506_NM569
20230506_NM564
20230506_NM563
20230506_NM559
20230506_NM555
20230506_NM549
20230506_NM508
20230506_NM474
20230506_NM136
20230506_NM124
20230506_NM118
20230506_NM094

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.